Trevor J. Orchard

Active 1981–2024

Also published as
Trevor J Orchard
161
Papers
32,080
Citations
97
h-index
158
i10-index

Citations

Citations per year for Trevor J. Orchard1969: 1 citations1982: 1 citations1984: 4 citations1985: 5 citations1986: 3 citations1987: 9 citations1988: 4 citations1989: 10 citations1990: 12 citations1991: 19 citations1992: 26 citations1993: 18 citations1994: 35 citations1995: 35 citations1996: 64 citations1997: 61 citations1998: 48 citations1999: 60 citations2000: 95 citations2001: 117 citations2002: 132 citations2003: 178 citations2004: 134 citations2005: 174 citations2006: 191 citations2007: 186 citations2008: 205 citations2009: 166 citations2010: 178 citations2011: 146 citations2012: 186 citations2013: 202 citations2014: 285 citations2015: 251 citations2016: 241 citations2017: 291 citations2018: 281 citations2019: 937 citations2020: 966 citations2021: 944 citations2022: 741 citations2023: 521 citations2024: 1,001 citations2025: 487 citations2026: 28 citations1970–1981: no citations, so these years are not shown1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,066 citing papers, 24.3% of this breakdownChina: 1,208 citing papers, 9.6% of this breakdownUnited Kingdom: 990 citing papers, 7.8% of this breakdownAustralia: 574 citing papers, 4.5% of this breakdownItaly: 500 citing papers, 4% of this breakdownGermany: 446 citing papers, 3.5% of this breakdownCanada: 409 citing papers, 3.2% of this breakdownIndia: 339 citing papers, 2.7% of this breakdownNetherlands: 273 citing papers, 2.2% of this breakdownSpain: 265 citing papers, 2.1% of this breakdownFrance: 247 citing papers, 2% of this breakdownDenmark: 243 citing papers, 1.9% of this breakdown
0%24.3%Other 32.2%

Fields

  • Medicine76.3%
  • Biochemistry, Genetics and Molecular Biology12.9%
  • Immunology and Microbiology2.3%
  • Health Professions2.3%
  • Dentistry1.6%
  • Neuroscience1.5%
  • Other3.1%

Topics

  • Retinal Diseases and Treatments6.5%
  • Diabetes Management and Research6.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins5.2%
  • Retinal Imaging and Analysis4.3%
  • Diabetes and associated disorders4.2%
  • Diabetes Treatment and Management4%
  • Other69.4%

Coauthors

All papers

Open in search
  1. Global Prevalence and Major Risk Factors of Diabetic Retinopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sheila K. West, Liang Xu, Miho Yasuda, Xinzhi Zhang, Paul Mitchell, Tien Yin Wong, for the Meta-Analysis for Eye Disease (META-EYE) Study Group - Diabetes Care 2012 cited by 4,904

  2. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2022 cited by 1,092

  3. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Constance Wou, Ronald C W Ma, Maria I Schmidt, Ambady Ramachandran, Yutaka Seino, Peter H Bennett, Brian Oldenburg, Juan José Gagliardino, Andrea O Y Luk, Philip M Clarke, Graham D Ogle, Melanie J Davies, Rury R Holman, Edward W Gregg - The Lancet 2020 cited by 737

  4. Can clinical factors estimate insulin resistance in type 1 diabetes?

    Authors: , , , , - Diabetes 2000 cited by 610

  5. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study

    Authors: , , , , , , , , , , , - Circulation 2022 cited by 168

  6. Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis

    Authors: , , , , , , , , , , , , , , - Cell Metabolism 2013 cited by 576

  7. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study

    Authors: , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2016 cited by 522

  8. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

    Authors: , , , , , , , , , - Diabetes 2020 cited by 213

  9. Prevalence of Diagnosed Diabetes in Adults by Diabetes Type — United States, 2016

    Authors: , , , , , , , , - MMWR Morbidity and Mortality Weekly Report 2018 cited by 515

  10. Insulin Resistance–Related Factors, but not Glycemia, Predict Coronary Artery Disease in Type 1 Diabetes

    Authors: , , , , , , , - Diabetes Care 2003 cited by 495

  11. Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality

    Authors: , , , , , , - JAMA 2015 cited by 436

  12. Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association

    Authors: , , , , , , , , , , , - Diabetes Care 2014 cited by 429

  13. Understanding Metabolic Memory: A Tale of Two Studies

    Authors: , - Diabetes 2020 cited by 89

  14. Risk Factors for Kidney Disease in Type 1 Diabetes

    Authors: , , , , , , , , , , , , - Diabetes Care 2019 cited by 126

  15. Temporal patterns in overweight and obesity in Type 1 diabetes

    Authors: , , , , , , - Diabetic Medicine 2010 cited by 328

  16. Improvements in the Life Expectancy of Type 1 Diabetes

    Authors: , , , , - Diabetes 2012 cited by 294

  17. Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis

    Authors: , , , , , , , , , , , , , , , , , - Diabetes Care 2018 cited by 148

  18. Type 1 Diabetes Mellitus and Cardiovascular Disease

    Authors: , , , , , , , , , , , - Circulation 2014 cited by 501

  19. The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial

    Authors: , , , , , , - Annals of Internal Medicine 2005 cited by 943

  20. The 30-Year Natural History of Type 1 Diabetes Complications

    Authors: , , , , , - Diabetes 2006 cited by 491

  21. Defining Pathways for Development of Disease-Modifying Therapies in Children With Type 1 Diabetes: A Consensus Report

    Authors: , , , , , , , , , , , , , - Diabetes Care 2015 cited by 92

  22. Long‐term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study

    Authors: , , , , , , , , , , , - Diabetic Medicine 2012 cited by 216

  23. Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC)

    Authors: , , - Diabetes 2018 cited by 111

  24. Does diabetes prevention translate into reduced long-term vascular complications of diabetes?

    Authors: , , , , , , , , , , , - Diabetologia 2019 cited by 90